Cross-Platform Comparison of Four Leading Technologies for Detecting EGFR Mutations in Circulating Tumor DNA from Non-Small Cell Lung Carcinoma Patient Plasma

Theranostics
Ting XuGuobing Xu

Abstract

Analysis of circulating tumor DNA (ctDNA) is emerging as a powerful tool for guiding targeted therapy and monitoring tumor evolution in patients with non-small cell lung cancer (NSCLC), especially when representative tissue biopsies are not available. Here, we have compared the ability of four leading technology platforms to detect epidermal growth factor receptor (EGFR) mutations (L858R, exon 19 deletion, T790M and G719X) in ctDNA from NSCLC patients. Two amplification refractory mutation systems (cobas-ARMS and ADx-ARMS), a droplet digital polymerase chain reaction (ddPCR) and a next-generation sequencing (Firefly NGS) platform were included in the comparison. Fifteen EGFR mutations across twenty NSCLC patients were identified. Firefly NGS, cobas-ARMS and ddPCR all displayed superior sensitivity while ADx-ARMS was better suited for the qualitative detection of EGFR mutations with allele frequency higher than 1% in plasma and tissue samples. We observed high coincidence between the plasma and tissue EGFR mutational profiles for three driver mutations (L858R, exon 19 deletion and G719X) that are known targets of first generation EGFR-TKI therapies among patients who relapsed. Discrepancies between tissue and plasma EGFR mutatio...Continue Reading

Citations

Mar 14, 2019·The Prostate·Michael T SchweizerColin C Pritchard
Mar 28, 2019·Genetic Testing and Molecular Biomarkers·Matthew ScarlottaAmy K Kim
Nov 7, 2019·Targeted Oncology·Zhengquan YangChunming Ding
Dec 11, 2019·Diagnostics·Antonia HarangușMărioara Șimon
Nov 7, 2019·Journal of Cancer Research and Clinical Oncology·Yuan TangDongmei Lin
Jul 25, 2019·Angewandte Chemie·Jagotamoy Das, Shana O Kelley
Apr 12, 2020·Journal of Cellular and Molecular Medicine·Nan WuZhihong Wu
Sep 14, 2019·Journal of Oral and Maxillofacial Pathology : JOMFP·Deepa BabjiVijayalakshmi Kotrashetti
Feb 14, 2019·Nucleic Acids Research·Alexander R GawrońskiFaraz Hach
Mar 14, 2019·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J GaoJ-Y Ding
Dec 21, 2019·PloS One·Eirini PapadopoulouGeorge Nasioulas
May 29, 2020·Journal of Pathology and Translational Medicine·Sunhee ChangWan Seop Kim
Mar 6, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jason D MerkerNicholas C Turner
Jun 5, 2019·Clinical and Translational Science·Federico M Goodsaid
Sep 23, 2020·International Journal of Molecular Sciences·Melinda SzilágyiBálint Nagy
Apr 4, 2019·Molecular Diagnosis & Therapy·Re-I ChinAadel A Chaudhuri
Oct 28, 2019·Thoracic Cancer·Taehee KimYoon Soo Chang
May 16, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maria CoakleyNicholas C Turner
Dec 6, 2019·Clinica Chimica Acta; International Journal of Clinical Chemistry·Yingyin LiaoAiwu Wu
Jan 17, 2020·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Eva Boysen Fynboe EbertPeter Meldgaard
Feb 10, 2020·The Journal of Molecular Diagnostics : JMD·Chan XiangYuchen Han
Dec 8, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M YangW Zhang

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
PCR
biopsies
deamination
blood draw

Software Mentioned

SPSS
GraphPad Prism
cobas
Firefly
ARMS
ADx
QuantaSoft

Related Concepts

Related Feeds

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.